Why is Senores Pharma. falling/rising?

As of 30-Jun, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 584.00, reflecting a rise of 16.1 points or 2.84%. The stock has shown strong performance recently, outperforming its sector by 2.15% today, and it reached an intraday high of Rs 585, which is a 3.01% increase. Over the past week, the stock has gained 11.09%, and over the past month, it has risen by 11.61%. Despite this positive momentum, there are concerns regarding falling investor participation, as the delivery volume has decreased significantly by 42.57% against the 5-day average. Additionally, while the company has a low debt-to-equity ratio and impressive growth in net sales and operating profit, the recent flat results and high valuation metrics may be causing some caution among investors.
In the broader market context, Senores Pharmaceuticals has outperformed the Sensex, which has only increased by 2.09% over the past week and 2.65% over the past month. However, the stock's year-to-date return of 2.65% is notably lower than the Sensex's 7.00% increase, indicating that while the stock is currently rising, it may not be keeping pace with the overall market in the longer term. The decline in institutional investor participation, with a 10.3% reduction in their stake, could also be influencing market sentiment negatively, as these investors typically have more resources to assess the company's fundamentals.